Pericytes from human veins for treatment of myocardial ischemia

Rajesh G. Katare, Paolo Madeddu

Research output: Contribution to journalArticlepeer-review


Stem cell therapies promise to regenerate the infarcted heart through the replacement of dead cardiac cells and stimulation of neovascularization. New research from our laboratory shows the transplantation of stem cells from human veins helps heart healing after an acute ischemic insult. Using a mouse model, we demonstrated that pericytes expanded from redundant human leg veins relocate around the vessels of the peri-infarct zone and release factors that promote reparative angiogenesis and cardiomyocyte survival and inhibit interstitial fibrosis. We plan to perform a first-in-man clinical trial with human pericytes in patients with refractory myocardial ischemia in the next 5 years.

Original languageEnglish
Pages (from-to)66-70
Number of pages5
JournalTrends in Cardiovascular Medicine
Issue number3
Publication statusPublished - Apr 2013

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Pericytes from human veins for treatment of myocardial ischemia'. Together they form a unique fingerprint.

Cite this